|
[1]
|
Stoop, T.F., Javed, A.A., Oba, A., Koerkamp, B.G., Seufferlein, T., Wilmink, J.W., et al. (2025) Pancreatic Cancer. The Lancet, 405, 1182-1202.
https://doi.org/10.1016/s0140-6736(25)00261-2
|
|
[2]
|
Connor, A.A. and Gallinger, S. (2022) Pancreatic Cancer Evolution and Heterogeneity: Integrating Omics and Clinical Data. Nature Reviews Cancer, 22, 131-142.
https://doi.org/10.1038/s41568-021-00418-1
|
|
[3]
|
National Cancer Institute (2026) Cancer Stat Facts: Pancreatic Cancer.
https://seer.cancer.gov/statfacts/html/pancreas.html
|
|
[4]
|
Wainberg, Z.A., Manji, G.A., Bahary, N., Ulahannan, S.V., Pant, S., Spigel, D.R., et al. (2026) Quemliclustat and Chemotherapy with or without Zimberelimab in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase 1 Trial. Nature Medicine, 32, 1267-1277.
https://doi.org/10.1038/s41591-026-04283-z
|
|
[5]
|
Kawalerski, R.R., Leach, S.D. and Escobar-Hoyos, L.F. (2021) Pancreatic Cancer Driver Mutations Are Targetable through Distant Alternative RNA Splicing Dependencies. Oncotarget, 12, 525-533.
https://doi.org/10.18632/oncotarget.27901
|
|
[6]
|
Xu, Y.F., Xu, X., Gin, A., Nshimiyimana, J.D., Mooers, B.H.M., Caputi, M., et al. (2020) SRSF1 Regulates Exosome microRNA Enrichment in Human Cancer Cells. Cell Communication and Signaling, 18, 130-142.
https://doi.org/10.1186/s12964-020-00615-9
|
|
[7]
|
Chen, S., Yang, C., Wang, Z.W., Hu, J., Pan, J., Liao, C., et al. (2021) CLK1/SRSF5 Pathway Induces Aberrant Exon Skipping of METTL14 and Cyclin L2 and Promotes Growth and Metastasis of Pancreatic Cancer. Journal of Hematology & Oncology, 14, 60-83.
https://doi.org/10.1186/s13045-021-01072-8
|
|
[8]
|
Li, M., Wu, P., Yang, Z., et al. (2020) miR-193a-5p Promotes Pancreatic Cancer Cell Metastasis through SRSF6-Mediated Alternative Splicing of OGDHL and ECM. American Journal of Cancer Research, 10, 38-59.
|
|
[9]
|
Schultz, J., Jones, T., Bork, P., Sheer, D., Blencke, S., Steyrer, S., et al. (2001) Molecular Characterization of a cDNA Encoding Functional Human CLK4 Kinase and Localization to Chromosome 4q35. Genomics, 71, 368-370.
https://doi.org/10.1006/geno.2000.6447
|
|
[10]
|
Liu, Y., Conaway, L., Rutherford Bethard, J., Al-Ayoubi, A.M., Thompson Bradley, A., Zheng, H., et al. (2013) Phosphorylation of the Alternative mRNA Splicing Factor 45 (SPF45) by CLK1 Regulates Its Splice Site Utilization, Cell Migration and Invasion. Nucleic Acids Research, 41, 4949-4962.
https://doi.org/10.1093/nar/gkt170
|
|
[11]
|
Karlas, A., Machuy, N., Shin, Y., Pleissner, K., Artarini, A., Heuer, D., et al. (2010) Genome-Wide RNAi Screen Identifies Human Host Factors Crucial for Influenza Virus Replication. Nature, 463, 818-822.
https://doi.org/10.1038/nature08760
|
|
[12]
|
Yang, C., Wu, Y., Tu, H., Yeh, Y., Lin, T.E., Sung, T., et al. (2025) Identification and Biological Evaluation of a Novel CLK4 Inhibitor Targeting Alternative Splicing in Pancreatic Cancer Using Structure‐Based Virtual Screening. Advanced Science, 12, Article ID: 2416323.
https://doi.org/10.1002/advs.202416323
|
|
[13]
|
Jiang, Y., Tang, Z., Jiang, M., Wang, J. and Wang, Y. (2025) Small Molecule Inhibitors Targeting Cdc2‐Like Kinase 4: Advances, Challenges, and Opportunities. Chemical Biology & Drug Design, 105, e70087.
https://doi.org/10.1111/cbdd.70087
|
|
[14]
|
Tam, B.Y., Chiu, K., Chung, H., Bossard, C., Nguyen, J.D., Creger, E., et al. (2020) The CLK Inhibitor SM08502 Induces Anti-Tumor Activity and Reduces Wnt Pathway Gene Expression in Gastrointestinal Cancer Models. Cancer Letters, 473, 186-197.
https://doi.org/10.1016/j.canlet.2019.09.009
|
|
[15]
|
Fedorov, O., Huber, K., Eisenreich, A., Filippakopoulos, P., King, O., Bullock, A.N., et al. (2011) Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing. Chemistry & Biology, 18, 67-76.
https://doi.org/10.1016/j.chembiol.2010.11.009
|
|
[16]
|
Kawakita, Y., Kojima, T., Nii, N., Ito, Y., Sakauchi, N., Banno, H., et al. (2025) Discovery of Rogocekib (CTX-712): A Potent and Selective CLK Inhibitor for Cancer Treatment. ACS Medicinal Chemistry Letters, 16, 1870-1875.
https://doi.org/10.1021/acsmedchemlett.5c00412
|
|
[17]
|
Li, S., Chen, X., Shi, H., Yi, M., Xiong, B. and Li, T. (2025) Tailoring Traditional Chinese Medicine in Cancer Therapy. Molecular Cancer, 24, Article No. 27.
https://doi.org/10.1186/s12943-024-02213-6
|
|
[18]
|
Yen, S.C., Chen, L.C., Huang, H.L., HuangFu, W., Chen, Y., Eight Lin, T., et al. (2022) Identification of a Dual FLT3 and MNK2 Inhibitor for Acute Myeloid Leukemia Treatment Using a Structure-Based Virtual Screening Approach. Bioorganic Chemistry, 121, Article ID: 105675.
https://doi.org/10.1016/j.bioorg.2022.105675
|
|
[19]
|
Shi, M., He, J., Weng, T., Shi, N., Qi, W., Guo, Y., et al. (2022) The Binding Mechanism of NHWD-870 to Bromodomain-Containing Protein 4 Based on Molecular Dynamics Simulations and Free Energy Calculation. Physical Chemistry Chemical Physics, 24, 5125-5137.
https://doi.org/10.1039/d1cp05490b
|
|
[20]
|
Burley, S.K., Bhikadiya, C., Bi, C., Bittrich, S., Chen, L., Crichlow, G.V., et al. (2021) RCSB Protein Data Bank: Powerful New Tools for Exploring 3D Structures of Biological Macromolecules for Basic and Applied Research and Education in Fundamental Biology, Biomedicine, Biotechnology, Bioengineering and Energy Sciences. Nucleic Acids Research, 49, D437-D451.
https://doi.org/10.1093/nar/gkaa1038
|
|
[21]
|
Webb, B. and Sali, A. (2017) Comparative Protein Structure Modeling Using MODELLER. Current Protocols in Bioinformatics, 54, 5.6.1-5.6.37.
https://doi.org/10.1002/cpbi.3
|
|
[22]
|
Ravindranath, P.A., Forli, S., Goodsell, D.S., Olson, A.J. and Sanner, M.F. (2015) AutoDockFR: Advances in Protein-Ligand Docking with Explicitly Specified Binding Site Flexibility. PLOS Computational Biology, 11, e1004586.
https://doi.org/10.1371/journal.pcbi.1004586
|
|
[23]
|
Jia, Y., Gao, B., Tan, J., et al. (2026) Deep Contrastive Learning Enables Genome-Wide Virtual Screening. Science, 391, ads9530.
https://doi.org/10.1126/science.ads9530
|
|
[24]
|
Gao, K., Liu, L., Lei, S., Li, Z., Huo, P., Wang, Z., et al. (2025) HERB 2.0: An Updated Database Integrating Clinical and Experimental Evidence for Traditional Chinese Medicine. Nucleic Acids Research, 53, D1404-D1414.
https://doi.org/10.1093/nar/gkae1037
|
|
[25]
|
López-López, E., Naveja, J.J. and Medina-Franco, J.L. (2019) DataWarrior: An Evaluation of the Open-Source Drug Discovery Tool. Expert Opinion on Drug Discovery, 14, 335-341.
https://doi.org/10.1080/17460441.2019.1581170
|
|
[26]
|
O’Boyle, N.M., Banck, M., James, C.A., Morley, C., Vandermeersch, T. and Hutchison, G.R. (2011) Open Babel: An Open Chemical Toolbox. Journal of Cheminformatics, 3, Article No. 33.
https://doi.org/10.1186/1758-2946-3-33
|
|
[27]
|
Eberhardt, J., Santos-Martins, D., Tillack, A.F. and Forli, S. (2021) AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings. Journal of Chemical Information and Modeling, 61, 3891-3898.
https://doi.org/10.1021/acs.jcim.1c00203
|
|
[28]
|
Case, D.A., Cheatham, T.E., Darden, T., Gohlke, H., Luo, R., Merz, K.M., et al. (2005) The Amber Biomolecular Simulation Programs. Journal of Computational Chemistry, 26, 1668-1688.
https://doi.org/10.1002/jcc.20290
|
|
[29]
|
Roe, D.R. and Cheatham, T.E. (2013) PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data. Journal of Chemical Theory and Computation, 9, 3084-3095.
https://doi.org/10.1021/ct400341p
|
|
[30]
|
Humphrey, W., Dalke, A. and Schulten, K. (1996) VMD: Visual Molecular Dynamics. Journal of Molecular Graphics, 14, 33-38.
https://doi.org/10.1016/0263-7855(96)00018-5
|
|
[31]
|
Bouysset, C. and Fiorucci, S. (2021) ProLIF: A Library to Encode Molecular Interactions as Fingerprints. Journal of Cheminformatics, 13, Article No. 72.
https://doi.org/10.1186/s13321-021-00548-6
|